2021
DOI: 10.3389/fonc.2021.601957
|View full text |Cite
|
Sign up to set email alerts
|

Defining the Extracellular Matrix of Rhabdomyosarcoma

Abstract: Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma of childhood with a propensity to metastasize. Current treatment for patients with RMS includes conventional systemic chemotherapy, radiation therapy, and surgical resection; nevertheless, little to no improvement in long term survival has been achieved in decades—underlining the need for target discovery and new therapeutic approaches to targeting tumor cells or the tumor microenvironment. To evaluate cross-species sarcoma extracellular matrix prod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 34 publications
(45 reference statements)
0
8
0
Order By: Relevance
“…Fibrillin-2 (FBN2), first expressed at the site of contact between epithelial and mesenchymal cells, is an extracellular calcium-binding microfibril involved in multiple biological pathways, including bone mineralization, osteoblast maturation, and calcium-binding ( 28 ). It has been identified as a diagnostic biomarker for smooth muscle sarcoma and rhabdomyosarcoma ( 29 , 30 ). However, studies on FBN2 have focused on its methylation, and aberrant methylation of FBN2 has been found in breast cancer, non-small cell lung cancer, and esophageal squamous cell carcinoma ( 31 33 ), and the promoter region of the FBN2 gene has been repeatedly reported to be hypermethylated in several types of cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Fibrillin-2 (FBN2), first expressed at the site of contact between epithelial and mesenchymal cells, is an extracellular calcium-binding microfibril involved in multiple biological pathways, including bone mineralization, osteoblast maturation, and calcium-binding ( 28 ). It has been identified as a diagnostic biomarker for smooth muscle sarcoma and rhabdomyosarcoma ( 29 , 30 ). However, studies on FBN2 have focused on its methylation, and aberrant methylation of FBN2 has been found in breast cancer, non-small cell lung cancer, and esophageal squamous cell carcinoma ( 31 33 ), and the promoter region of the FBN2 gene has been repeatedly reported to be hypermethylated in several types of cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Most previous studies focused on events that happened within tumor cells, several recent studies addressed the role of the microenvironment in tumor tissue components when stimulating tumor progression, invasion, and metastasis 29,30 . The mechanism of tumor–stroma interaction is of therapeutic importance.…”
Section: Discussionmentioning
confidence: 99%
“…Given previous studies suggesting the importance of the extracellular matrix (ECM) in sarcoma, 17 we investigated the expression patterns of extracellular matrix genes in EPS (Figure S6 ). Four ECM genes were significantly overexpressed in distal EPS ( COL4A1 , 3.3× overexpression, COL5A , 4.2× overexpression, COL12A1 , 2.5× overexpression, COLEC12 , 1.5× overexpression), but significance did not hold true under multiple comparison testing.…”
Section: Resultsmentioning
confidence: 99%